Immunotherapeutic treatment for inducing the regression of...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 16/18 (2006.01) A61K 31/33 (2006.01) A61K 39/00 (2006.01) A61K 39/395 (2006.01) A61P 9/10 (2006.01) G01N 33/53 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2621017

The use of immunotherapy against oxidised LDL to induce regression of preexisting atherosclerotic lesions in an individual. The immunotherapy can be passive immunotherapy utilising antibodies that bind to epitopes present on oxidised LDL, or active immunotherapy utilising a vaccine composition for induction of an immune response against epitopes present on oxidised LDL.

L'invention concerne l'utilisation de l'immunothérapie contre la LDL oxydée pour induire une régression des lésions athéroscléreuses préexistantes chez un individu. Cette immunothérapie peut être une immunothérapie passive utilisant des anticorps qui se lient à des épitopes présents sur la LDL oxydée ou une immunothérapie active utilisant une composition vaccinale pour induire une réponse immunitaire contre des épitopes présents sur la LDL oxydée.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Immunotherapeutic treatment for inducing the regression of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunotherapeutic treatment for inducing the regression of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunotherapeutic treatment for inducing the regression of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1994844

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.